Trials / Enrolling By Invitation
Enrolling By InvitationNCT07150221
MDR Vivacit-E Elevated Study
Post-Market Clinical Follow-Up Study of the Vivacit-E Vitamin E Highly Crosslinked Polyethylene HXLPE Elevated Liners in Primary THA- A Retrospective Enrollment/Prospective Follow-Up Study
- Status
- Enrolling By Invitation
- Phase
- —
- Study type
- Observational
- Enrollment
- 52 (estimated)
- Sponsor
- Zimmer Biomet · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The main objective of this study is to confirm long-term safety, performance, and clinical benefits of the Vivacit-E Vitamin E HXLPE Elevated Liners when used in primary total hip arthroplasty.
Conditions
- Osteoarthritis (OA) of the Hip
- Avascular Necrosis of Bone of Hip
- Protrusio Acetabuli
- Traumatic Arthropathy-Hip
- Slipped Capital Femoral Epiphyses
- Fused Hip
- Fracture of Pelvis
- Diastrophic Variant
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Vivacit-E Elevated Liners | Primary total hip arthroplasty |
Timeline
- Start date
- 2026-01-07
- Primary completion
- 2027-12-01
- Completion
- 2027-12-01
- First posted
- 2025-09-02
- Last updated
- 2026-04-01
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT07150221. Inclusion in this directory is not an endorsement.